Extracellular vesicles in hematological malignancies: From biology to therapy

International Journal of Molecular Sciences

Volumn 18, Issue 6, 2017, Pages

  Caivano, Antonella ^a   La Rocca, Francesco ^a   Laurenzana, Ilaria ^a   Trino, Stefania ^a   De Luca, Luciana ^a   Lamorte, Daniela ^a   Del Vecchio, Luigi ^b   Musto, Pellegrino ^a  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Biomarkers; Bone marrow microenvironment; Drug resistance; Extracellular vesicles; Hematological malignancies; Therapeutic tools

Indexed keywords

TUMOR MARKER;

AUTOCRINE EFFECT; BLOOD CLOTTING; BONE MARROW; CANCER IMMUNOTHERAPY; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL SURVIVAL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STORAGE; EXOSOME; EXTRACELLULAR MATRIX; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; MOLECULAR INTERACTION; NONHUMAN; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; REVIEW; TISSUE REPAIR; TUMOR CELL; TUMOR MICROENVIRONMENT; ANIMAL; HEMATOLOGIC DISEASE; PATHOLOGY;

ANIMALS; BONE MARROW; CELL COMMUNICATION; EXTRACELLULAR VESICLES; HEMATOLOGIC NEOPLASMS; HUMANS; TUMOR MICROENVIRONMENT;

EID: 85020422033     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18061183     Document Type: Review

References (186)

1. Maas, S.L., Breakefield, X.O., Weaver, A.M. Extracellular vesicles: Unique intercellular delivery vehicles. Trends Cell Biol. 2017, 27, 172-188.
2. Cocucci, E., Meldolesi, J. Ectosomes and exosomes: Shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015, 25, 364-372.
3. Vader, P., Breakefield, X.O., Wood, M.J. Extracellular vesicles: Emerging targets for cancer therapy. Trends Mol. Med. 2014, 20, 385-393.
4. Minciacchi, V.R., Freeman, M.R., di Vizio, D. Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol. 2015, 40, 41-51.
5. Meehan, B., Rak, J., di Vizio, D. Oncosomes-large and small: What are they, where they came from? J. Extracell. Vesicles 2016, 5, 33109.
6. Zaborowski, M.P., Balaj, L., Breakefield, X.O., Lai, C.P. Extracellular vesicles: Composition, biological relevance, and methods of study. Bioscience 2015, 65, 783-797.
7. Skotland, T., Sandvig, K., Llorente, A. Lipids in exosomes: Current knowledge and the way forward. Prog. Lipid Res. 2017, 66, 30-41.
8. Kim, K.M., Abdelmohsen, K., Mustapic, M., Kapogiannis, D., Gorospe, M. RNA in extracellular vesicles. Wiley Interdiscip. Rev. RNA 2017.
9. Raposo, G., Stoorvogel, W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200, 373-383.
10. Bellingham, S.A., Coleman, B.M., Hill, A.F. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012, 40, 10937-10949.
11. Nolte-’t Hoen, E.N., Buermans, H.P., Waasdorp, M., Stoorvogel, W., Wauben, M.H., ’t Hoen, P.A. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 2012, 40, 9272-9285.
12. Mateescu, B., Kowal, E.J., van Balkom, B.W., Bartel, S., Bhattacharyya, S.N., Buzas, E.I., Buck, A.H., de Candia, P., Chow, F.W., Das, S., et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA—An ISEV position paper. J. Extracell. Vesicles 2017, 6, 1286095.
13. Falchi, A.M., Sogos, V., Saba, F., Piras, M., Congiu, T., Piludu, M. Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP. Histochem. Cell Biol. 2013, 139, 221-231.
14. Kim, D.K., Lee, J., Kim, S.R., Choi, D.S., Yoon, Y.J., Kim, J.H., Go, G., Nhung, D., Hong, K., Jang, S.C., et al. EVpedia: A community web portal for extracellular vesicles research. Bioinformatics 2015, 31, 933-939.
15. Kalra, H., Simpson, R.J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V.C., Borras, F.E., Breakefield, X., Budnik, V., et al. Vesiclepedia: A compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012, 10, e1001450.
16. Keerthikumar, S., Chisanga, D., Ariyaratne, D., Al Saffar, H., Anand, S., Zhao, K., Samuel, M., Pathan, M., Jois, M., Chilamkurti, N., et al. Exocarta: A web-based compendium of exosomal cargo. J. Mol. Biol. 2016, 428, 688-692.
17. Dozio, V., Sanchez, J.C. Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure. J. Extracell. Vesicles 2017, 6, 1302705.
18. Yanez-Mo, M., Siljander, P.R., Andreu, Z., Zavec, A.B., Borras, F.E., Buzas, E.I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 2015, 4, 27066.
19. Witas, R., Chaput, D., Khan, H., Stevens, S.M., Jr., Kang, D. Isolation and proteomic analysis of microvesicles and exosomes from HT22 cells and primary neurons. Methods Mol. Biol. 2017, 1598, 255-267.
20. Dostert, G., Mesure, B., Menu, P., Velot, E. How do mesenchymal stem cells influence or are influenced by microenvironment through extracellular vesicles communication? Front. Cell Dev. Biol. 2017, 5, 6.
21. Naito, Y., Yoshioka, Y., Yamamoto, Y., Ochiya, T. How cancer cells dictate their microenvironment: Present roles of extracellular vesicles. Cell. Mol. Life Sci. 2017, 74, 697-713.
22. Kucharzewska, P., Christianson, H.C., Welch, J.E., Svensson, K.J., Fredlund, E., Ringner, M., Morgelin, M., Bourseau-Guilmain, E., Bengzon, J., Belting, M. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. USA 2013, 110, 7312-7317.
23. Rice, G.E., Scholz-Romero, K., Sweeney, E., Peiris, H., Kobayashi, M., Duncombe, G., Mitchell, M.D., Salomon, C. The effect of glucose on the release and bioactivity of exosomes from first trimester trophoblast cells. J. Clin. Endocrinol. Metab. 2015, 100, E1280-E1288.
24. Turturici, G., Tinnirello, R., Sconzo, G., Geraci, F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: Advantages and disadvantages. Am. J. Phys. Cell Phys. 2014, 306, C621-C633.
25. Aubertin, K., Silva, A.K., Luciani, N., Espinosa, A., Djemat, A., Charue, D., Gallet, F., Blanc-Brude, O., Wilhelm, C. Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy. Sci. Rep. 2016, 6, 35376.
26. Prada, I., Meldolesi, J. Binding and fusion of extracellular vesicles to the plasma membrane of their cell targets. Int. J. Mol. Sci. 2016, 17, 1296.
27. Mulcahy, L.A., Pink, R.C., Carter, D.R. Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles 2014, 3, 24641.
28. Rappa, G., Santos, M.F., Green, T.M., Karbanova, J., Hassler, J., Bai, Y., Barsky, S.H., Corbeil, D., Lorico, A. Nuclear transport of cancer extracellular vesicle-derived biomaterials through nuclear envelope invagination-associated late endosomes. Oncotarget 2017, 8, 14443-14461.
29. Yuana, Y., Sturk, A., Nieuwland, R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013, 27, 31-39.
30. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654-659.
31. Gatti, S., Bruno, S., Deregibus, M.C., Sordi, A., Cantaluppi, V., Tetta, C., Camussi, G. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 2011, 26, 1474-1483.
32. Qian, Z., Shen, Q., Yang, X., Qiu, Y., Zhang, W. The role of extracellular vesicles: An epigenetic view of the cancer microenvironment. BioMed Res. Int. 2015, 2015, 649161.
33. Andaloussi, S.E., Mager, I., Breakefield, X.O., Wood, M.J. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 2013, 12, 347-357.
34. French, K.C., Antonyak, M.A., Cerione, R.A. Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake. Semin. Cell Dev. Biol. 2017.
35. Cappello, F., Logozzi, M., Campanella, C., Bavisotto, C.C., Marcilla, A., Properzi, F., Fais, S. Exosome levels in human body fluids: A tumor marker by themselves? Eur. J. Pharm. Sci. 2017, 96, 93-98.
36. Caivano, A., Laurenzana, I., de Luca, L., La Rocca, F., Simeon, V., Trino, S., D’Auria, F., Traficante, A., Maietti, M., Izzo, T., et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol. 2015, 36, 9739-9752.
37. Ogawa, Y., Miura, Y., Harazono, A., Kanai-Azuma, M., Akimoto, Y., Kawakami, H., Yamaguchi, T., Toda, T., Endo, T., Tsubuki, M., et al. Proteomic analysis of two types of exosomes in human whole saliva. Biol. Pharm. Bull. 2011, 34, 13-23.
38. Aalberts, M., van Dissel-Emiliani, F.M., van Adrichem, N.P., van Wijnen, M., Wauben, M.H., Stout, T.A., Stoorvogel, W. Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, Annexin A1, and GLIPR2 in humans. Biol. Reprod. 2012, 86, 82.
39. Melnik, B.C., John, S.M., Schmitz, G. Milk: An exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy? J. Transl. Med. 2014, 12, 43.
40. Kolhe, R., Hunter, M., Liu, S., Jadeja, R.N., Pundkar, C., Mondal, A.K., Mendhe, B., Drewry, M., Rojiani, M.V., Liu, Y., et al. Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci. Rep. 2017, 7, 2029.
41. Van Balkom, B.W., Pisitkun, T., Verhaar, M.C., Knepper, M.A. Exosomes and the kidney: Prospects for diagnosis and therapy of renal diseases. Kidney Int. 2011, 80, 1138-1145.
42. Balbi, C., Piccoli, M., Barile, L., Papait, A., Armirotti, A., Principi, E., Reverberi, D., Pascucci, L., Becherini, P., Varesio, L., et al. First characterization of human amniotic fluid stem cell extracellular vesicles as a powerful paracrine tool endowed with regenerative potential. Stem Cells Transl. Med. 2017, 6, 1340-1355.
43. Menay, F., Herschlik, L., de Toro, J., Cocozza, F., Tsacalian, R., Gravisaco, M.J., di Sciullo, M.P., Vendrell, A., Waldner, C.I., Mongini, C. Exosomes isolated from ascites of T-cell lymphoma-bearing mice expressing surface CD24 and HSP-90 induce a tumor-specific immune response. Front. Immunol. 2017, 8, 286.
44. Lee, J., McKinney, K.Q., Pavlopoulos, A.J., Han, M.H., Kim, S.H., Kim, H.J., Hwang, S. Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis. Clin. Chim. Acta 2016, 462, 118-126.
45. Fais, S., O’Driscoll, L., Borras, F.E., Buzas, E., Camussi, G., Cappello, F., Carvalho, J., Cordeiro da Silva, A., del Portillo, H., El Andaloussi, S., et al. Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano 2016, 10, 3886-3899.
46. Surman, M., Stepien, E., Hoja-Lukowicz, D., Przybylo, M. Deciphering the role of ectosomes in cancer development and progression: Focus on the proteome. Clin. Exp. Metastasis 2017.
47. Peinado, H., Zhang, H., Matei, I.R., Costa-Silva, B., Hoshino, A., Rodrigues, G., Psaila, B., Kaplan, R.N., Bromberg, J.F., Kang, Y., et al. Pre-metastatic niches: Organ-specific homes for metastases. Nat. Rev. Cancer 2017, 17, 302-317.
48. Whiteside, T.L. Exosomes carrying immunoinhibitory proteins and their role in cancer. Clin. Exp. Immunol. 2017.
49. Raimondo, S., Corrado, C., Raimondi, L., de Leo, G., Alessandro, R. Role of extracellular vesicles in hematological malignancies. BioMed Res. Int. 2015, 2015, 821613.
50. Boyiadzis, M., Whiteside, T.L. Information transfer by exosomes: A new frontier in hematologic malignancies. Blood Rev. 2015, 29, 281-290.
51. Zhang, L., Valencia, C.A., Dong, B., Chen, M., Guan, P.J., Pan, L. Transfer of micrornas by extracellular membrane microvesicles: A nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions. J. Hematol. Oncol. 2015, 8, 14.
52. Robbins, P.D., Morelli, A.E. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 2014, 14, 195-208.
53. Nawaz, M., Fatima, F., Vallabhaneni, K.C., Penfornis, P., Valadi, H., Ekstrom, K., Kholia, S., Whitt, J.D., Fernandes, J.D., Pochampally, R., et al. Extracellular vesicles: Evolving factors in stem cell biology. Stem Cells Int. 2016, 2016, 1073140.
54. Nomura, S., Niki, M., Nisizawa, T., Tamaki, T., Shimizu, M. Microparticles as biomarkers of blood coagulation in cancer. Biomark. Cancer 2015, 7, 51-56.
55. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., Ratajczak, M.Z. Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20, 1487-1495.
56. Jiang, J., Woulfe, D.S., Papoutsakis, E.T. Shear enhances thrombopoiesis and formation of microparticles that induce megakaryocytic differentiation of stem cells. Blood 2014, 124, 2094-2103.
57. Lamichhane, T.N., Sokic, S., Schardt, J.S., Raiker, R.S., Lin, J.W., Jay, S.M. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tissue Eng. Part B Rev. 2015, 21, 45-54.
58. Xin, H., Li, Y., Cui, Y., Yang, J.J., Zhang, Z.G., Chopp, M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab. 2013, 33, 1711-1715.
59. Lee, Y., El Andaloussi, S., Wood, M.J. Exosomes and microvesicles: Extracellular vesicles for genetic information transfer and gene therapy. Hum. Mol. Genet. 2012, 21, R125-R134.
60. Tannetta, D., Dragovic, R., Alyahyaei, Z., Southcombe, J. Extracellular vesicles and reproduction-promotion of successful pregnancy. Cell. Mol. Immunol. 2014, 11, 548-563.
61. Clayton, A., Mitchell, J.P., Court, J., Linnane, S., Mason, M.D., Tabi, Z. Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol. 2008, 180, 7249-7258.
62. Yu, B., Zhang, X., Li, X. Exosomes derived from mesenchymal stem cells. Int. J. Mol. Sci. 2014, 15, 4142-4157.
63. Jong, A.Y., Wu, C.H., Li, J., Sun, J., Fabbri, M., Wayne, A.S., Seeger, R.C. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J. Extracell. Vesicles 2017, 6, 1294368.
64. Burrello, J., Monticone, S., Gai, C., Gomez, Y., Kholia, S., Camussi, G. Stem cell-derived extracellular vesicles and immune-modulation. Front. Cell Dev. Biol. 2016, 4, 83.
65. Di Trapani, M., Bassi, G., Midolo, M., Gatti, A., Kamga, P.T., Cassaro, A., Carusone, R., Adamo, A., Krampera, M. Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions. Sci. Rep. 2016, 6, 24120.
66. Berckmans, R.J., Sturk, A., van Tienen, L.M., Schaap, M.C., Nieuwland, R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 2011, 117, 3172-3180.
67. Ng, Y.H., Rome, S., Jalabert, A., Forterre, A., Singh, H., Hincks, C.L., Salamonsen, L.A. Endometrial exosomes/microvesicles in the uterine microenvironment: A new paradigm for embryo-endometrial cross talk at implantation. PLoS ONE 2013, 8, e58502.
68. Bakhti, M., Winter, C., Simons, M. Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J. Biol. Chem. 2011, 286, 787-796.
69. Wang, S., Cesca, F., Loers, G., Schweizer, M., Buck, F., Benfenati, F., Schachner, M., Kleene, R. Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via Glia-derived exosomes. J. Neurosci. 2011, 31, 7275-7290.
70. Mendelson, A., Frenette, P.S. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat. Med. 2014, 20, 833-846.
71. Anthony, B.A., Link, D.C. Regulation of hematopoietic stem cells by bone marrow stromal cells. Trends Immunol. 2014, 35, 32-37.
72. Javeed, N., Mukhopadhyay, D. Exosomes and their role in the micro-/macro-environment: A comprehensive review. J. Biomed. Res. 2016, 30, 1-9.
73. Arendt, B.K., Walters, D.K., Wu, X., Tschumper, R.C., Jelinek, D.F. Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation. Oncotarget 2014, 5, 5686-5699.
74. Wu, X.-H. Leukemia-derived exosomes induce paracrine and autocrine cell proliferation in pediatric ALL. In Proceedings of the 58thASHAnnualMeeting and Exposition, SanDiego, CA, USA, 3-6December 2016, p. 4080.
75. Milani, G., Lana, T., Bresolin, S., Aveic, S., Pasto, A., Frasson, C., Te Kronnie, G. Expression profiling of circulating microvesicles reveals intercellular transmission of oncogenic pathways. Mol. Cancer Res. 2017.
76. Patel, S.J., Darie, C.C., Clarkson, B.D. Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density. Am. J. Transl. Res. 2016, 8, 3614-3629
77. Raimondo, S., Saieva, L., Corrado, C., Fontana, S., Flugy, A., Rizzo, A., de Leo, G., Alessandro, R. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Cell Commun. Signal. 2015, 13, 8.
78. Paggetti, J., Haderk, F., Seiffert, M., Janji, B., Distler, U., Ammerlaan, W., Kim, Y.J., Adam, J., Lichter, P., Solary, E., et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood 2015, 126, 1106-1117.
79. Zhou, S., Abdouh, M., Arena, V., Arena, M., Arena, G.O. Reprogramming malignant cancer cells toward a benign phenotype following exposure to human embryonic stem cell microenvironment. PLoS ONE 2017, 12, e0169899.
80. Wang, Y., Cheng, Q., Liu, J., Dong, M. Leukemia stem cell-released microvesicles promote the survival and migration of myeloid leukemia cells and these effects can be inhibited by microRNA34a overexpression. Stem Cells Int. 2016, 2016, 9313425.
81. Hornick, N.I., Doron, B., Abdelhamed, S., Huan, J., Harrington, C.A., Shen, R., Cambronne, X.A., Chakkaramakkil Verghese, S., Kurre, P. AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. Sci. Signal. 2016, 9, ra88.
82. Huan, J., Hornick, N.I., Goloviznina, N.A., Kamimae-Lanning, A.N., David, L.L., Wilmarth, P.A., Mori, T., Chevillet, J.R., Narla, A., Roberts, C.T., Jr., et al. Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes. Leukemia 2015, 29, 2285-2295.
83. Razmkhah, F., Soleimani, M., Mehrabani, D., Karimi, M.H., Amini Kafi-Abad, S., Ramzi, M., Iravani Saadi, M., Kakoui, J. Leukemia microvesicles affect healthy hematopoietic stem cells. Tumour Biol. 2017, 39.
84. Gu, H., Chen, C., Hao, X., Wang, C., Zhang, X., Li, Z., Shao, H., Zeng, H., Yu, Z., Xie, L., et al. Sorting protein VPS33B regulates exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis. J. Clin. Investig. 2016, 126, 4537-4553.
85. Koch, R., Demant, M., Aung, T., Diering, N., Cicholas, A., Chapuy, B., Wenzel, D., Lahmann, M., Guntsch, A., Kiecke, C., et al. Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma. Blood 2014, 123, 2189-2198.
86. Bruno, S., Deregibus, M.C., Camussi, G. The secretome of mesenchymal stromal cells: Role of extracellular vesicles in immunomodulation. Immunol. Lett. 2015, 168, 154-158.
87. Robbins, P.D., Dorronsoro, A., Booker, C.N. Regulation of chronic inflammatory and immune processes by extracellular vesicles. J. Clin. Investig. 2016, 126, 1173-1180.
88. Busch, A., Quast, T., Keller, S., Kolanus, W., Knolle, P., Altevogt, P., Limmer, A. Transfer of T cell surface molecules to dendritic cells upon CD4+ T cell priming involves two distinct mechanisms. J. Immunol. 2008, 181, 3965-3973.
89. Hedlund, M., Nagaeva, O., Kargl, D., Baranov, V., Mincheva-Nilsson, L. Thermal-and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS ONE 2011, 6, e16899.
90. Xie, Y., Zhang, H., Li, W., Deng, Y., Munegowda, M.A., Chibbar, R., Qureshi, M., Xiang, J. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity. J. Immunol. 2010, 185, 5268-5278.
91. Baier, C., Fino, A., Sanchez, C., Farnault, L., Rihet, P., Kahn-Perles, B., Costello, R.T. Natural killer cells modulation in hematological malignancies. Front. Immunol. 2013, 4, 459.
92. Reiners, K.S., Topolar, D., Henke, A., Simhadri, V.R., Kessler, J., Sauer, M., Bessler, M., Hansen, H.P., Tawadros, S., Herling, M., et al. Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity. Blood 2013, 121, 3658-3665.
93. Wang, J., Faict, S., Maes, K., de Bruyne, E., van Valckenborgh, E., Schots, R., Vanderkerken, K., Menu, E. Extracellular vesicle cross-talk in the bone marrow microenvironment: Implications in multiple myeloma. Oncotarget 2016, 7, 38927-38945.
94. Wang, J., de Veirman, K., Faict, S., Frassanito, M.A., Ribatti, D., Vacca, A., Menu, E. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression. J. Pathol. 2016, 239, 162-173.
95. Garg, T.K., Gann, J.I., Malaviarachchi, P.A., Stone, K., Macleod, V., Greenway, A.D., Morgan, G.J. Myeloma-derived exosomes and soluble factors suppress natural killer cell function. In Proceedings of 58th ASH Annual Meeting and Exposition, San Diego, CA, USA, 3-6 December 2016, p. 2066.
96. Chillemi, A., Quarona, V., Antonioli, L., Ferrari, D., Horenstein, A.L., Malavasi, F. Roles and modalities of ectonucleotidases in remodeling the multiple myeloma niche. Front. Immunol. 2017, 8, 305.
97. Malavasi, F. CD38 and antibody therapy: What can basic science add? Proceedings of 58th ASH Annual Meeting and Exposition, San Diego, CA, USA, 3-6 December 2016, p. SCI-36.
98. Gutzeit, C., Nagy, N., Gentile, M., Lyberg, K., Gumz, J., Vallhov, H., Puga, I., Klein, E., Gabrielsson, S., Cerutti, A., et al. Exosomes derived from Burkitt’s lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells. J. Immunol. 2014, 192, 5852-5862.
99. Hansen, H.P., Engels, H.M., Dams, M., Paes Leme, A.F., Pauletti, B.A., Simhadri, V.L., Durkop, H., Reiners, K.S., Barnert, S., Engert, A., et al. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin’s lymphoma. J. Pathol. 2014, 232, 405-414.
100. Zhou, J., Wang, S., Sun, K., Chng, W.J. The emerging roles of exosomes in leukemogeneis. Oncotarget 2016, 7, 50698-50707.
101. Hong, C.S., Muller, L., Whiteside, T.L., Boyiadzis, M. Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia. Front. Immunol. 2014, 5, 160.
102. Roccaro, A.M., Sacco, A., Maiso, P., Azab, A.K., Tai, Y.T., Reagan, M., Azab, F., Flores, L.M., Campigotto, F., Weller, E., et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J. Clin. Investig. 2013, 123, 1542-1555.
103. Wang, J., Hendrix, A., Hernot, S., Lemaire, M., de Bruyne, E., van Valckenborgh, E., Lahoutte, T., de Wever, O., Vanderkerken, K., Menu, E. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood 2014, 124, 555-566.
104. Corrado, C., Raimondo, S., Saieva, L., Flugy, A.M., de Leo, G., Alessandro, R. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett. 2014, 348, 71-76.
105. Bruno, S., Collino, F., Iavello, A., Camussi, G. Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth. Front. Immunol. 2014, 5, 382.
106. Ghosh, A.K., Secreto, C.R., Knox, T.R., Ding, W., Mukhopadhyay, D., Kay, N.E. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: Implications for disease progression. Blood 2010, 115, 1755-1764.
107. Boysen, J., Nelson, M., Magzoub, G., Maiti, G.P., Sinha, S., Goswami, M., Vesely, S.K., Shanafelt, T.D., Kay, N.E., Ghosh, A.K. Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: Implication in disease progression. Leukemia 2017, 31, 350-360.
108. Farahani, M., Rubbi, C., Liu, L., Slupsky, J.R., Kalakonda, N. Cll exosomes modulate the transcriptome and behaviour of recipient stromal cells and are selectively enriched in miR-202-3p. PLoS ONE 2015, 10, e0141429.
109. Fei, F., Joo, E.J., Tarighat, S.S., Schiffer, I., Paz, H., Fabbri, M., Abdel-Azim, H., Groffen, J., Heisterkamp, N. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through galectin-3. Oncotarget 2015, 6, 11378-11394.
110. Johnson, S.M., Dempsey, C., Chadwick, A., Harrison, S., Liu, J., Di, Y., McGinn, O.J., Fiorillo, M., Sotgia, F., Lisanti, M.P., et al. Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia. Blood 2016, 128, 453-456.
111. Umezu, T., Tadokoro, H., Azuma, K., Yoshizawa, S., Ohyashiki, K., Ohyashiki, J.H. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood 2014, 124, 3748-3757.
112. Liu, Y., Zhu, X.J., Zeng, C., Wu, P.H., Wang, H.X., Chen, Z.C., Li, Q.B. Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharm. Sin. 2014, 35, 230-238.
113. Raimondi, L., De Luca, A., Amodio, N., Manno, M., Raccosta, S., Taverna, S., Bellavia, D., Naselli, F., Fontana, S., Schillaci, O., et al. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget 2015, 6, 13772-13789.
114. Vardaki, I., Sanchez, C., Fonseca, P., Olsson, M., Chioureas, D., Rassidakis, G., Ullen, A., Zhivotovsky, B., Bjorkholm, M., Panaretakis, T. Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells. Blood 2016, 128, 2655-2665.
115. El-Saghir, J., Nassar, F., Tawil, N., El-Sabban, M. ATL-derived exosomes modulate mesenchymal stem cells: Potential role in leukemia progression. Retrovirology 2016, 13, 73.
116. Horiguchi, H., Kobune, M., Kikuchi, S., Yoshida, M., Murata, M., Murase, K., Iyama, S., Takada, K., Sato, T., Ono, K., et al. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms. Haematologica 2016, 101, 437-447.
117. Huan, J., Hornick, N.I., Shurtleff, M.J., Skinner, A.M., Goloviznina, N.A., Roberts, C.T., Jr., Kurre, P. RNA trafficking by acute myelogenous leukemia exosomes. Cancer Res. 2013, 73, 918-929.
118. Muntion, S., Ramos, T.L., Diez-Campelo, M., Roson, B., Sanchez-Abarca, L.I., Misiewicz-Krzeminska, I., Preciado, S., Sarasquete, M.E., de Las Rivas, J., Gonzalez, M., et al. Microvesicles from mesenchymal stromal cells are involved in HPC-microenvironment crosstalk in myelodysplastic patients. PLoS ONE 2016, 11, e0146722.
119. Ramos, T.L., Sánchez-Abarca, L.I., Rosón, B. Extracellular vesicles play an important role in intercellular communication between bone marrow stroma and hematopoietic progenitor cells in myeloproliferative neoplasms. In Proceedings of the 58th ASH Annual Meeting and Exposition, San Diego, CA, USA, 3-6 December 2016, p. 1957.
120. Umezu, T., Ohyashiki, K., Kuroda, M., Ohyashiki, J.H. Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 2013, 32, 2747-2755.
121. Zhu, X., You, Y., Li, Q., Zeng, C., Fu, F., Guo, A., Zhang, H., Zou, P., Zhong, Z., Wang, H., et al. BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: Implications for donor cell leukemia. Leukemia 2014, 28, 1666-1675.
122. Gutkin, A., Uziel, O., Beery, E., Nordenberg, J., Pinchasi, M., Goldvaser, H., Henick, S., Goldberg, M., Lahav, M. Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells. Oncotarget 2016, 7, 59173-59188.
123. Jaiswal, R.K., Kumar, P., Yadava, P.K. Telomerase and its extracurricular activities. Cell. Mol. Biol. Lett. 2013, 18, 538-554.
124. Purushothaman, A., Bandari, S.K., Liu, J., Mobley, J.A., Brown, E.E., Sanderson, R.D. Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions. J. Biol. Chem. 2016, 291, 1652-1663.
125. Redzic, J.S., Kendrick, A.A., Bahmed, K., Dahl, K.D., Pearson, C.G., Robinson, W.A., Robinson, S.E., Graner, M.W., Eisenmesser, E.Z. Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-β1 and EMMPRIN. PLoS ONE 2013, 8, e71225.
126. Cesi, G., Walbrecq, G., Margue, C., Kreis, S. Transferring intercellular signals and traits between cancer cells: Extracellular vesicles as “homing pigeons”. Cell Commun. Signal. 2016, 14, 13.
127. Gong, J., Luk, F., Jaiswal, R., George, A.M., Grau, G.E., Bebawy, M. Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance. Eur. J. Pharm. 2013, 721, 116-125.
128. Sousa, D., Lima, R.T., Vasconcelos, M.H. Intercellular transfer of cancer drug resistance traits by extracellular vesicles. Trends Mol. Med. 2015, 21, 595-608.
129. Koch, R., Aung, T., Vogel, D., Chapuy, B., Wenzel, D., Becker, S., Sinzig, U., Venkataramani, V., von Mach, T., Jacob, R., et al. Nuclear trapping through inhibition of exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and pixantrone. Clin. Cancer Res. 2016, 22, 395-404.
130. D’Arena, G., Ruggieri, V., D’Auria, F., La Rocca, F., Simeon, V., Statuto, T., Caivano, A., Telesca, D., del Vecchio, L., Musto, P. Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells. Leuk. Lymphoma 2015, 56, 2458-2459.
131. Aung, T., Chapuy, B., Vogel, D., Wenzel, D., Oppermann, M., Lahmann, M., Weinhage, T., Menck, K., Hupfeld, T., Koch, R., et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc. Natl. Acad. Sci. USA 2011, 108, 15336-15341.
132. Viola, S., Traer, E., Huan, J., Hornick, N.I., Tyner, J.W., Agarwal, A., Loriaux, M., Johnstone, B., Kurre, P. Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance. Br. J. Haematol. 2016, 172, 983-986.
133. Wojtuszkiewicz, A., Schuurhuis, G.J., Kessler, F.L., Piersma, S.R., Knol, J.C., Pham, T.V., Jansen, G., Musters, R.J., van Meerloo, J., Assaraf, Y.G., et al. Exosomes secreted by apoptosis-resistant acute myeloid leukemia (AML) blasts harbor regulatory network proteins potentially involved in antagonism of apoptosis. Mol. Cell. Proteom. 2016, 15, 1281-1298.
134. Bouvy, C., Wannez, A., Chatelain, C.J., Dogné, J.-M. Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their micrornas cargo. In Proceedings of the 58th ASH Annual Meeting and Exposition, San Diego, CA, USA, 3-6 December 2016, p. 2864.
135. Hansen, H.P., Trad, A., Dams, M., Zigrino, P., Moss, M., Tator, M., Schon, G., Grenzi, P.C., Bachurski, D., Aquino, B., et al. CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with brentuximab-vedotin, in vitro. Oncotarget 2016, 7, 30523-30535.
136. Siravegna, G., Marsoni, S., Siena, S., Bardelli, A. Integrating liquid biopsies into the management of cancer. Nat. Rev. Clin. Oncol. 2017.
137. De Luca, L., D’Arena, G., Simeon, V., Trino, S., Laurenzana, I., Caivano, A., La Rocca, F., Villani, O., Mansueto, G., Deaglio, S., et al. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia. Leuk. Lymphoma 2017, 58, 1424-1432.
138. Belov, L., Matic, K.J., Hallal, S., Best, O.G., Mulligan, S.P., Christopherson, R.I. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J. Extracell. Vesicles 2016, 5, 25355.
139. Caivano, A., La Rocca, F., Simeon, V., Girasole, M., Dinarelli, S., Laurenzana, I., de Stradis, A., de Luca, L., Trino, S., Traficante, A., et al. MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies—A short report. Cell. Oncol. 2017, 40, 97-103.
140. Yeh, Y.Y., Ozer, H.G., Lehman, A.M., Maddocks, K., Yu, L., Johnson, A.J., Byrd, J.C. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood 2015, 125, 3297-3305.
141. Van Eijndhoven, M.A., Zijlstra, J.M., Groenewegen, N.J., Drees, E.E., van Niele, S., Baglio, S.R., Koppers-Lalic, D., van der Voorn, H., Libregts, S.F., Wauben, M.H., et al. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight 2016, 1, e89631.
142. Bouyssou, J.M.C., Aljawai, Y., Yosef, A., Manier, S., Rawal, R., Kokubun, K., Roccaro, A.M. Profiling of Circulating Exosomes in Patients withWaldenström Macroglobulinemia. In Proceedings of the 58th ASH Annual Meeting and Exposition, San Diego, CA, USA, 3-6 December 2016, Volume 128, p. 2940.
143. Krishnan, S.R., Luk, F., Brown, R.D., Suen, H., Kwan, Y., Bebawy, M. Isolation of human CD138+ microparticles from the plasma of patients with multiple myeloma. Neoplasia 2016, 18, 25-32.
144. Xie, Y., Bai, O., Zhang, H., Yuan, J., Zong, S., Chibbar, R., Slattery, K., Qureshi, M., Wei, Y., Deng, Y., et al. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8+ CTLand NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J. Cell. Mol. Med. 2010, 14, 2655-2666.
145. Harshman, S.W., Canella, A., Ciarlariello, P.D., Agarwal, K., Branson, O.E., Rocci, A., Cordero, H., Phelps, M.A., Hade, E.M., Dubovsky, J.A., et al. Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. J. Proteom. 2016, 136, 89-98.
146. Di Noto, G., Paolini, L., Zendrini, A., Radeghieri, A., Caimi, L., Ricotta, D. C-src enriched serum microvesicles are generated in malignant plasma cell dyscrasia. PLoS ONE 2013, 8, e70811.
147. Manier, S., Liu, C.J., Avet-Loiseau, H., Park, J., Shi, J., Campigotto, F., Salem, K.Z., Huynh, D., Glavey, S.V., Rivotto, B., et al. Prognostic role of circulating exosomal mirnas in multiple myeloma. Blood 2017, 129, 2429-2436.
148. Feng, D.Q., Huang, B., Li, J., Liu, J., Chen, X.M., Xu, Y.M., Chen, X., Zhang, H.B., Hu, L.H., Wang, X.Z. Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes. Asian Pac. J. Cancer Prev. 2013, 14, 7501-7508.
149. Ohyashiki, K., Umezu, T., Katagiri, S., Kobayashi, C., Azuma, K., Tauchi, T., Okabe, S., Fukuoka, Y., Ohyashiki, J.H. Downregulation of plasma miR-215 in chronic myeloid leukemia patients with successful discontinuation of imatinib. Int. J. Mol. Sci. 2016, 17, 570.
150. Hong, C.S., Muller, L., Boyiadzis, M., Whiteside, T.L. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS ONE 2014, 9, e103310.
151. Szczepanski, M.J., Szajnik, M., Welsh, A., Whiteside, T.L., Boyiadzis, M. Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-β1. Haematologica 2011, 96, 1302-1309.
152. Boyiadzis, M., Whiteside, T.L. Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: Are we ready? Expert Rev. Mol. Diagn. 2016, 16, 623-629.
153. Lia, G., Brunello, L., Omedè, P., Astolfi, M., Drandi, D., Giaccone, L., Evangelista, A. Extracellular Vesicles as Potential Biomarker for Acute Graft-Versus-Host-Disease. In Proceedings of the 58th ASH Annual Meeting and Exposition, San Diego, CA, USA, 3-6 December 2016, p. 2239.
154. Aoki, J., Ohashi, K., Mitsuhashi, M., Murakami, T., Oakes, M., Kobayashi, T., Doki, N., Kakihana, K., Sakamaki, H. Posttransplantation bone marrow assessment by quantifying hematopoietic cell-derived mRNAs in plasma exosomes/microvesicles. Clin. Chem. 2014, 60, 675-682.
155. H Rashed, M., Bayraktar, E., K Helal, G., Abd-Ellah, M.F., Amero, P., Chavez-Reyes, A., Rodriguez-Aguayo, C. Exosomes: From garbage bins to promising therapeutic targets. Int. J. Mol. Sci. 2017, 18, 538.
156. Zhang, B., Yin, Y., Lai, R.C., Lim, S.K. Immunotherapeutic potential of extracellular vesicles. Front. Immunol. 2014, 5, 518.
157. Syn, N.L., Wang, L., Chow, E.K., Lim, C.T., Goh, B.C. Exosomes in cancer nanomedicine and immunotherapy: Prospects and challenges. Trends Biotechnol. 2017.
158. Yao, Y., Wang, C., Wei, W., Shen, C., Deng, X., Chen, L., Ma, L., Hao, S. Dendritic cells pulsed with leukemia cell-derived exosomes more efficiently induce antileukemic immunities. PLoS ONE 2014, 9, e91463.
159. Yao, Y., Wei, W., Sun, J., Chen, L., Deng, X., Ma, L., Hao, S. Proteomic analysis of exosomes derived from human lymphoma cells. Eur. J. Med. Res. 2015, 20, 8.
160. Shen, C., Hao, S.G., Zhao, C.X., Zhu, J., Wang, C. Antileukaemia immunity: Effect of exosomes against NB4 acute promyelocytic leukaemia cells. J. Int. Med. Res. 2011, 39, 740-747.
161. Qazi, K.R., Gehrmann, U., Domange Jordo, E., Karlsson, M.C., Gabrielsson, S. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 2009, 113, 2673-2683.
162. Gehrmann, U., Naslund, T.I., Hiltbrunner, S., Larssen, P., Gabrielsson, S. Harnessing the exosome-induced immune response for cancer immunotherapy. Semin. Cancer Biol. 2014, 28, 58-67.
163. Rani, S., Ryan, A.E., Griffin, M.D., Ritter, T. Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Mol. Ther. 2015, 23, 812-823.
164. De Luca, L., Trino, S., Laurenzana, I., Lamorte, D., Caivano, A., del Vecchio, L., Musto, P. Mesenchymal stem cell derived extracellular vesicles: A role in hematopoietic transplantation? Int. J. Mol. Sci. 2017, 18, 1022.
165. De Luca, L., Trino, S., Laurenzana, I., Simeon, V., Calice, G., Raimondo, S., Podesta, M., Santodirocco, M., di Mauro, L., La Rocca, F., et al. miRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: A new insight in transplantation. Oncotarget 2016, 7, 6676-6692.
166. Kordelas, L., Rebmann, V., Ludwig, A.K., Radtke, S., Ruesing, J., Doeppner, T.R., Epple, M., Horn, P.A., Beelen, D.W., Giebel, B. MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014, 28, 970-973.
167. Baietti, M.F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., et al. Syndecan-syntenin-alix regulates the biogenesis of exosomes. Nat. Cell Biol. 2012, 14, 677-685.
168. Marchaland, J., Cali, C., Voglmaier, S.M., Li, H., Regazzi, R., Edwards, R.H., Bezzi, P. Fast subplasma membrane Ca2+ transients control exo-endocytosis of synaptic-like microvesicles in astrocytes. J. Neurosci. 2008, 28, 9122-9132.
169. Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J.P., Boireau, W., Rouleau, A., Simon, B., Lanneau, D., et al. Membrane-associated HSP72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Investig. 2010, 120, 457-471.
170. Christianson, H.C., Svensson, K.J., van Kuppevelt, T.H., Li, J.P., Belting, M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc. Natl. Acad. Sci. USA 2013, 110, 17380-17385.
171. Lima, L.G., Chammas, R., Monteiro, R.Q., Moreira, M.E., Barcinski, M.A. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett. 2009, 283, 168-175.
172. Shtam, T.A., Kovalev, R.A., Varfolomeeva, E.Y., Makarov, E.M., Kil, Y.V., Filatov, M.V. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun. Signal. 2013, 11, 88.
173. Nishida-Aoki, N., Tominaga, N., Takeshita, F., Sonoda, H., Yoshioka, Y., Ochiya, T. Disruption of circulating extracellular vesicles as a novel therapeutic strategy against cancer metastasis. Mol. Ther. 2017, 25, 181-191.
174. Gustafson, H.H., Holt-Casper, D., Grainger, D.W., Ghandehari, H. Nanoparticle uptake: The phagocyte problem. Nano Today 2015, 10, 487-510.
175. Teissier, E., Pecheur, E.I. Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur. Biophys. J. 2007, 36, 887-899.
176. Hoshino, A., Costa-Silva, B., Shen, T.L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., di Giannatale, A., Ceder, S., et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015, 527, 329-335.
177. Barile, L., Vassalli, G. Exosomes: Therapy delivery tools and biomarkers of diseases. Pharm. Ther. 2017, 174, 63-78.
178. Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G.J., Wei, J., Nie, G. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 2014, 35, 2383-2390.
179. Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., Zhang, H.G. A novel nanoparticle drug delivery system: The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 2010, 18, 1606-1614.
180. Lunavat, T.R., Jang, S.C., Nilsson, L., Park, H.T., Repiska, G., Lasser, C., Nilsson, J.A., Gho, Y.S., Lotvall, J. RNAi delivery by exosome-mimetic nanovesicles-implications for targeting c-Myc in cancer. Biomaterials 2016, 102, 231-238.
181. Wiklander, O.P., Nordin, J.Z., O’Loughlin, A., Gustafsson, Y., Corso, G., Mager, I., Vader, P., Lee, Y., Sork, H., Seow, Y., et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 2015, 4, 26316.
182. Lener, T., Gimona, M., Aigner, L., Borger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F.A., Del Portillo, H.A., et al. Applying extracellular vesicles based therapeutics in clinical trials—An ISEV position paper. J. Extracell. Vesicles 2015, 4, 30087.
183. Lorincz, A.M., Timar, C.I., Marosvari, K.A., Veres, D.S., Otrokocsi, L., Kittel, A., Ligeti, E. Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes. J. Extracell. Vesicles 2014, 3, 25465.
184. Sokolova, V., Ludwig, A.K., Hornung, S., Rotan, O., Horn, P.A., Epple, M., Giebel, B. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf. B Biointerfaces 2011, 87, 146-150.
185. Kalra, H., Adda, C.G., Liem, M., Ang, C.S., Mechler, A., Simpson, R.J., Hulett, M.D., Mathivanan, S. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics 2013, 13, 3354-3364.
186. Consortium, E.-T., van Deun, J., Mestdagh, P., Agostinis, P., Akay, O., Anand, S., Anckaert, J., Martinez, Z.A., Baetens, T., Beghein, E., et al. EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 2017, 14, 228-232.